News
Blazing the Trail to European Exports: Panaxia Israel Announces Receipt of EU-GMP Certification, Required for the Manufacture and European Export of Medical Cannabis and Advanced Products
June 11, 2020
June 11, 2020 | Yahoo Finance Dr. Dadi Segal, CEO of Panaxia Global, said, “Receiving EU-GMP certification is a defining moment for us and for the
Panaxia Global Reports Record Revenues for Its Israeli Activity in the First Quarter of 2020
June 8, 2020
June 8, 2020 | Market Watch Dr. Dadi Segal, CEO of Panaxia Global, said, “Panaxia started 2020 with a strong quarter boasting expanded operations, record quarterly
Europe’s Neuraxpharm, Israel’s Panaxia to sell medical cannabis in Germany
April 10, 2020
April 10, 2020 | Reuters Specialty drugmaker Neuraxpharm has teamed up with Israel’s Panaxia Labs to market medical cannabis, saying it would be the first
Panaxia To Use R&D Facility In Malta To Market Cannabis Across Europe
April 9, 2020
APRIL 9, 2020 | Cannabis Law Report Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd. (TASE: PNAX), announced a contractual agreement to use